About Landesklinikum St. Pölten
Das Universitätsklinikum St. Pölten ist ein Krankenhaus in Sankt Pölten und wird von der Landesgesundheitsagentur geführt. Es befindet sich am Dunant-Platz 1 im Norden der Stadt und ist mit ca. 1140 Betten das größte Krankenhaus Niederösterreichs.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
13
Bayer
7
Biotronik SE & Co. KG
5
Boston Scientific Corporation
3
Hoffmann-La Roche
3
Medical University of Graz
3
Medtronic Cardiac Rhythm and Heart Failure
3
Amgen
2
Shire
2
Abbott Medical Devices
1
Antisoma Research
1
Clinical Trials at Landesklinikum St. Pölten
During the past decade, Landesklinikum St. Pölten conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 17 clinical trials were completed, i.e. on
average, 45.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 6 clinical trials were completed. i.e. 42.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations
2003-03-01
2005-02-01
Completed
254
Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
2007-07-01
2011-05-01
Completed
300
Survival of Patients With Primary Prophylactic ICD Indication
2008-02-01
2014-07-01
Completed
504
Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
2008-08-21
2016-07-14
Completed
1,623
Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study
2007-06-01
Unknown status
420
Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas
2009-03-01
2013-04-09
Completed
861
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Landesklinikum St. Pölten" #1 sponsor was "Celgene" with 13 trials, followed by "Bayer" with 7 trials
sponsored, "Biotronik SE & Co. KG" with 5 trials sponsored, "Boston Scientific Corporation" with 3 trials sponsored and "Hoffmann-La Roche"
with 3 trials sponsored. Other sponsors include 25 different institutions and
companies that sponsored additional 29 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Landesklinikum St. Pölten"
#1 collaborator was "Medical University of Vienna" with 4 trials as a collaborator, "Klinikum Klagenfurt am Wörthersee" with 3 trials as a collaborator, "Landesklinikum Sankt Polten" with 3 trials as a collaborator, "Johannes Kepler University of Linz" with 2 trials as a collaborator and "Landesklinkum Wiener Neustadt" with 2 trials as a collaborator. Other collaborators include 131 different institutions and companies that were
collaborators in the rest 138 trials.
Clinical Trials Conditions at Landesklinikum St. Pölten
According to Clinical.Site data, the most researched conditions in "Landesklinikum St. Pölten" are
"Heart Failure" (5 trials), "Melanoma" (4 trials), "Multiple Myeloma" (4 trials), "Acute Myocardial Infarction" (3 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Landesklinikum St. Pölten" in a lesser frequency.
Clinical Trials Intervention Types at Landesklinikum St. Pölten
Most popular intervention types in "Landesklinikum St. Pölten" are "Drug" (39 trials), "Other" (14 trials), "Device" (12 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Dexamethasone" (3 trials), "Gemcitabine" (3 trials), "Ozanimod" (3 trials) and "Bortezomib" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Landesklinikum St. Pölten
The vast majority of trials in "Landesklinikum St. Pölten" are
58 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Landesklinikum St. Pölten
Currently, there are NaN active trials in "Landesklinikum St. Pölten".
undefined are not yet recruiting,
19 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 31 completed trials in Landesklinikum St. Pölten,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Landesklinikum St. Pölten, 3 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 22 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 8 trials that are defined as “Not Applicable".
Departments of Landesklinikum St. Pölten
Landesklinikum St. Pölten has several departments that took part in Clinical trials: "Universitätsklinikum St. Pölten; Klinische Abteilung für Innere Medizin 1" - 5 trials, "Universitätsklinikum Tulln Abteilung fur Neurologie" - 3 trials, "Hospital Wiener Neustadt, Surgery" - 3 trials, "Univ.Klinikum Krems, Klin. Abt. f. Innere Medizin 2" - 2 trials, "Landesklinikum Wiener Neustadt; Innere Medizin, Hämatologie u. internistische Onkologie" - 2 trials
Departments List
Name
City
Trials